Section Arrow
RLAY.NASDAQ
- Relay Therapeutics
Quotes are at least 15-min delayed:2026/04/10 23:41 EDT
Regular Hours
Last
 14.94
-0.06 (-0.40%)
Day High 
15.42 
Prev. Close
15 
1-M High
15 
Volume 
2.79M 
Bid
14.3
Ask
15
Day Low
14.51 
Open
15 
1-M Low
9.265 
Market Cap 
2.68B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 11.78 
20-SMA 10.89 
50-SMA 9.82 
52-W High 15 
52-W Low 2.3 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.61/-1.56
Enterprise Value
2.71B
Balance Sheet
Book Value Per Share
3.17
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
15.36M
Operating Revenue Per Share
0.14
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CUECue Biopharma0.5019+0.209+71.36%-- 
QNCXQuince Therapeutics0.1363+0.0126+10.19%-- 
VRAXVirax Biolabs Group Limited0.1041-0.0308-22.83%-- 
ZNTLZentalis Pharmaceuticals6.61+2.19+49.55%-- 
IOVAIovance Biotherapeutics3.7-0.31-7.73%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.